RYDAF (RYDAF) Stock Price & Analysis
RYDAF (RYDAF) fell 0.50% to USD 43.78 as of July 25, 2026 at 03:08 UTC, according to Nexqual real-time market data.
RYDAF last closed at USD 44; the session ranged USD 44.4–44.4 on volume of 1,200 shares. Market capitalization is $242.27B, with a 52-week range of USD 33.55–47.9 (PNK). Source: Nexqual, July 25, 2026 at 03:08 UTC.
Key Statistics (as of July 25, 2026 at 03:08 UTC)
| Price | USD 43.78 |
|---|---|
| Change | ▼ 0.50% (down) |
| Previous Close | USD 44 |
| Open | USD 44.4 |
| Day Range | USD 44.4 – 44.4 |
| 52-Week Range | USD 33.55 – 47.9 |
| Volume | 1,200 shares |
| Market Cap | $242.27B |
| Exchange | PNK |
Technical Analysis (RYDAF)
Nexqual's technical model rates RYDAF "BUY" based on 5 bullish and 1 bearish signals across 124 daily candles, as of July 25, 2026 at 03:08 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 58.53 (neutral) |
| vs SMA50 | Above (USD 41.76) |
| MACD | 0.62 (positive) |
Analyst Ratings (RYDAF)
Wall Street analysts rate RYDAF "None", per Nexqual as of July 25, 2026 at 03:08 UTC.
| Consensus Rating | None |
|---|
Earnings (RYDAF)
| Next Earnings Date | 2026-07-30 |
|---|---|
| Revenue Estimate | $90.41B |
Source: Nexqual, July 25, 2026 at 03:08 UTC.
Financials & Fundamentals (RYDAF)
| Total Revenue | $267.34B |
|---|---|
| Revenue Growth (YoY) | +0.70% |
| Gross Margin | +25.86% |
| Operating Margin | +14.87% |
| Profit Margin | +7.01% |
| ROE | +10.70% |
| Debt / Equity | 43.32 |
| Current Ratio | 1.28 |
| Total Cash | $23.12B |
| Total Debt | $75.65B |
| Free Cash Flow | $15.63B |
Source: Nexqual, July 25, 2026 at 03:08 UTC.
Financial Health Score (RYDAF)
Nexqual rates RYDAF's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 03:08 UTC.
| Growth | Weak — Revenue -6% YoY (annual), declining |
|---|---|
| Profitability | Solid — Gross margin 26%, operating 15% |
| Balance Sheet | Solid — $23.1B cash vs $75.6B debt |
| Cash Flow | Solid — FCF $15.6B, 6% margin |
| Efficiency | Mixed — ROE 11%, ROA 5.0% |
Ownership (RYDAF)
| Insider Ownership | +0.06% |
|---|---|
| Institutional Ownership | +37.38% |
| Shares Outstanding | 5.53B |
| Float | 5.49B |
Source: Nexqual, July 25, 2026 at 03:08 UTC.
Leadership (RYDAF)
RYDAF is led by Wael Sawan (age 51), CEO & Director, per Nexqual as of July 25, 2026 at 03:08 UTC.
| CEO & Director | Wael Sawan (age 51) |
|---|---|
| CFO & Director | Sinead Gorman (age 48) |
| Executive Vice President of Chemicals | Graham Robert van't Hoff (age 63) |
| Executive Vice President of Finance Downstream | Brian Paul Eggleston |
| Senior Vice President of Finance Mobility | Roland Alexander Ilube |
Major Backers & Investors (RYDAF)
Notable institutional backers of RYDAF include Goldman Sachs, Capital Group, Fidelity, according to Nexqual as of July 25, 2026 at 03:08 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Goldman Sachs | 0.49% |
| Capital Group | 0.46% |
| Fidelity | 0.38% |
| First Eagle Funds-First Eagle Global Fund | 0.31% |
| AMERICAN BALANCED FUND | 0.3% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 2.48% |
| BlackRock | 1.37% |
Source: Nexqual, July 25, 2026 at 03:08 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| NVSEF | Novartis AG | USD 154.47 | ▲ 0.95% |
| BML-PH | Bank of America Corporation Dep | USD 18.72 | ▲ 0% |
| BML-PG | Bank of America Corporation Dep | USD 18.74 | ▼ 0.13% |
| LRLCF | L'Oreal Co. | USD 415 | ▼ 3.62% |
| BHPLF | BHP Group Limited | USD 42.3 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:08 UTC. This page is informational and not investment advice.